NCT01400438

Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast Cancer

Experience of the Patient Treated With Trastuzumab (Herceptin ®) as Adjuvant for Breast Cancer: Fatigue and Quality of Life During and Waning of Treatment, Psychosocial Aspects (Environment, Work)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 70 (actual)
• Sponsor: Centre Francois Baclesse · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Many studies have been devoted to the quality of life of patients during adjuvant chemotherapy for breast cancer by highlighting fatigue, psychological distress and impact on the immediate environment (spouse, children) during this difficult time for women. Curiously, no study to date has been submitted or published about how women with a one-year treatment "extra" Herceptin ® live this period in terms of quality of life, in terms of psychological impact for themselves and their families. The investigators have no more data on how often they return to work during this treatment or on the psycho-social parameters which underpin them. It therefore seemed interesting to "give a spotlight" on this particular period in these women HER2 + by comparing a patient population of same age receiving the same adjuvant but with no Herceptin ®.

Conditions

• Breast Cancer

Interventions

Type	Name	Description
OTHER	questionnaires	delivery of questionnaires and self-psychological interview
OTHER	questionnaires	delivery of questionnaires and self-psychological interview

Timeline

• Start date: 2011-07-01
• Primary completion: 2015-05-01
• Completion: 2015-09-01
• First posted: 2011-07-22
• Last updated: 2016-07-21

Locations

1 site across 1 country: France